Prolevare RSS Authorised This medicine is authorised for use in the European Union oclacitinib maleate Medicine Veterinary Authorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on Prolevare Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine Prolevare Active substance oclacitinib maleate International non-proprietary name (INN) or common name oclacitinib maleate Pharmacotherapeutic groupAgents for dermatitis, excluding corticosteroids Authorisation details EMA product number EMEA/V/C/006117 Assessment history Initial marketing authorisation documents CVMP summary of positive opinion for ProlevareAdopted Reference Number: EMA/CVMP/66932/2023 English (EN) (125.26 KB - PDF)First published: 17/02/2023 View News on Prolevare Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 202317/02/2023 This page was last updated on 15/02/2024 Share this page